•1 min read•from TechCrunch
H1 secures $40M from CVS, proving SaaS startups can still attract investment
CEO Ariel Katz argues that while AI can replicate workflow SaaS, it can't copy H1’s unique doctor data.
Want to read more?
Check out the full article on the original site